Neuphoria Therapeutics Inc.
NEUP
Clasificación en acciones
#29120
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Precio por acción
$3.92
Última sincronización: 2026-07-31
Capitalización bursátil
$21.16M
Cambio (1 día)
-0.13%
Cambio (1 año)
60,767.52%
País
US
Comercio Neuphoria Therapeutics Inc. (NEUP)
Categoría
Healthcare
Historial del precio de la acción de Neuphoria Therapeutics Inc. (NEUP)
Precio más alto de cierre: $0.01 el 2023-08-01
Precio más bajo de cierre: $0.56 el 1999-12-01
Precio más bajo de cierre: $0.56 el 1999-12-01
Historial del precio de la acción de Neuphoria Therapeutics Inc. desde 1999 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2023 | -78.35% |
| 2022 | -97.66% |
| 2021 | 1,363.12% |
| 2020 | 63.69% |
| 2019 | -30.83% |
| 2018 | -71.66% |
| 2017 | 18.70% |
| 2016 | -12.16% |
| 2015 | -19.29% |
| 2014 | -47.97% |
| 2013 | 95.06% |
| 2012 | -36.40% |
| 2011 | -90.46% |
| 2010 | 1,655.11% |
| 2009 | 133.43% |
| 2008 | -61.74% |
| 2007 | 121.34% |
| 2006 | 1.97% |
| 2005 | -16.73% |
| 2004 | -11.05% |
| 2003 | -22.47% |
| 2002 | -28.01% |
| 2001 | -20.19% |
| 2000 | -11.88% |
| 1999 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
